Updated Guidelines Issued for Management of Anaphylaxis
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 26, 2023 -- In a practice parameter update published online Dec. 17 in the Annals of Allergy, Asthma & Immunology, new guidelines are presented for the diagnosis and management of anaphylaxis.
David B. K. Golden, M.D.C.M., from the Johns Hopkins School of Medicine in Baltimore, and colleagues focused on seven areas with new evidence to update recommendations for the diagnosis of anaphylaxis in pediatric and adult patients.
The authors note that diagnostic criteria for anaphylaxis have been revised. For diagnosis of anaphylaxis and identification of underlying mast cell disorders, measurement of serum tryptase is important. Age-specific symptoms may differ for infants and toddlers versus older children and adults; no correlation has been seen for patient age with reaction severity. Anaphylaxis is unlikely to be the initial reaction to first exposure to an allergen. Specific measures for prevention and treatment of anaphylaxis are required for different community settings. Optimal prescribing and use of epinephrine autoinjector devices requires specific counseling and patient and caregiver training, including whether and when to call emergency medical services. Immediate activation of emergency medical services may not be required if the patient experiences a prompt, complete, and durable response to rapid use of epinephrine. For adult patients with severe insect sting anaphylaxis or recurrent idiopathic anaphylaxis, evaluation for mastocytosis, including a bone marrow biopsy, should be considered.
"These guidelines translate recent advances in the understanding of severe allergic reactions to help all health care professionals provide individualized care to each patient at the right time, in the right place, every time," Golden said in a statement.
Several authors disclosed financial ties to the pharmaceutical industry.
Anaphylaxis: Practice Parameter Update
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Recommendations Developed to Prepare Patients for Oral Immunotherapy
FRIDAY, April 19, 2024 -- In a research article published online April 8 in the Journal of Allergy and Clinical Immunology, consensus recommendations are presented for preparing...
Penicillin Allergy Can Be Delabeled by Nonallergy Providers
TUESDAY, April 9, 2024 -- Direct oral penicillin challenges (DPCs) can be delivered to patients with penicillin allergy labels (PALs) by nonallergy health care professionals...
American Academy of Allergy, Asthma & Immunology, Feb. 23 to 26
The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 23 to 26 in Washington, D.C., drawing participants from around the world...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.